Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 9, 2014, Pages 703-711

  Techasen, Anchalee ^a   Namwat, Nisana ^a,b   Loilome, Watcharin ^a,b   Duangkumpha, Kassaporn ^a,b   Puapairoj, Anucha ^a,b   Saya, Hideyuki ^c   Yongvanit, Puangrat ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholangiocarcinoma; Epithelial mesenchymal transition; S100A4; ZEB2

Indexed keywords

CALVASCULIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; PROTEIN S 100; REPRESSOR PROTEIN; S100A4 PROTEIN, HUMAN; TUMOR MARKER; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CELL MIGRATION; CELL MIGRATION ASSAY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; CELL MOTION; DISEASE COURSE; ENZYME IMMUNOASSAY; FLUORESCENCE MICROSCOPY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906344780     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.125     Document Type: Article

References (45)

1. Khuntikeo N, Pugkhem A, Titapun A, Bhudhisawasdi V,. Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. J Hepatobiliary Pancreat Sci. 2014; 21: 521-524.
2. Lee JM, Dedhar S, Kalluri R, Thompson EW,. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006; 172: 973-981.
3. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2: 442-454.
4. Thiery JP, Sleeman JP,. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7: 131-142.
5. Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu BC, et al. Epithelial- mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Oral Oncol. 2013; 49: 34-41.
6. Gomez I, Pena C, Herrera M, Munoz C, Larriba MJ, Garcia V, et al. TWIST1 is expressed in colorectal carcinomas and predicts patient survival. PLoS ONE. 2011; 6: e18023.
7. Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, et al. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res. 2011; 17: 7654-7663.
8. Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, et al. Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Med Oncol. 2012; 29: 3083-3091.
9. Nieto MA,. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002; 3: 155-166.
10. Vandewalle C, Van Roy F, Berx G,. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci. 2009; 66: 773-787.
11. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117: 927-939.
12. Zeisberg M, Neilson EG,. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009; 119: 1429-1437.
13. Dai YH, Tang YP, Zhu HY, Lv L, Chu Y, Zhou YQ, et al. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dig Dis Sci. 2012; 57: 1253-1260.
14. Ma X, Yang Y, Wang Y, An G, Lv G,. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Cancer Lett. 2010; 299: 171-181.
15. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA. 2006; 103: 14825-14830.
16. Takenaga K, Nygren J, Zelenina M, Ohira M, Iuchi T, Lukanidin E, et al. Modified expression of Mts1/S100A4 protein in C6 glioma cells or surrounding astrocytes affects migration of tumor cells in vitro and in vivo. Neurobiol Dis. 2007; 25: 455-463.
17. Zhang K, Zhang M, Zhao H, Yan B, Zhang D, Liang J,. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Dis Esophagus. 2012; 25: 731-739.
18. Hale MD, Hayden JD, Grabsch HI,. Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. Cell Oncol. 2013; 36: 95-112.
19. Wu Y, Zhou BP,. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010; 102: 639-644.
20. Balkwill F,. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9: 361-371.
21. Tanimura Y, Kokuryo T, Tsunoda N, Yamazaki Y, Oda K, Nimura Y, et al. Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett. 2005; 219: 205-213.
22. Bates RC, Mercurio AM,. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell. 2003; 14: 1790-1800.
23. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol. 2004; 165: 893-902.
24. Szlosarek P, Charles KA, Balkwill FR,. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer. 2006; 42: 745-750.
25. Morrisey K, Evans RA, Wakefield L, Phillips AO,. Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin. Am J Pathol. 2001; 159: 1905-1915.
26. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW,. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha. J Immunol. 1992; 149: 103-106.
27. Phillips AO, Topley N, Steadman R, Morrisey K, Williams JD,. Induction of TGF-beta 1 synthesis in d-glucose primed human proximal tubular cells by IL-1 beta and TNF alpha. Kidney Int. 1996; 50: 1546-1554.
28. Sullivan DE, Ferris M, Pociask D, Brody AR,. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol. 2008; 5: 145-149.
29. Sullivan DE, Ferris M, Pociask D, Brody AR,. Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol. 2005; 32: 342-349.
30. Thompson EW, Newgreen DF, Tarin D,. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005; 65: 5991-5995; discussion 5.
31. Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, et al. Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol. 2012; 25: 86-99.
32. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE. 2012; 7: e33788.
33. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2: 84-89.
34. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2: 76-83.
35. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem. 2002; 277: 39209-39216.
36. Hajra KM, Chen DY, Fearon ER,. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002; 62: 1613-1618.
37. Peinado H, Olmeda D, Cano A,. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007; 7: 415-428.
38. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem. 2001; 276: 27424-27431.
39. Vernon AE, LaBonne C,. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol. 2004; 14: R719-721.
40. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noel A, et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene. 2006; 25: 4975-4985.
41. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005; 33: 6566-6578.
42. Sato Y, Harada K, Sasaki M, Nakanuma Y,. Clinicopathological significance of S100 protein expression in cholangiocarcinoma. J Gastroenterol Hepatol. 2013; 28: 1422-1429.
43. Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, et al. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology. 2011; 54: 890-899.
44. Xie R, Schlumbrecht MP, Shipley GL, Xie S, Bassett RL Jr, Broaddus RR,. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab Invest. 2009; 89: 937-947.
45. Shirakihara T, Saitoh M, Miyazono K,. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell. 2007; 18: 3533-3544.